Cargando…
Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies
Primary central nervous system lymphoma (PCNSL) is a rare disease of the brain, spine, cerebrospinal fluid (CSF) and/or vitreoretinal space. PCNSL is chemo and radiosensitive but relapse is common even years after initial treatment. Outside of consensus regarding the use of high-dose methotrexate (H...
Autores principales: | Schaff, Lauren R., Ambady, Prakash, Doolittle, Nancy D., Grommes, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078860/ https://www.ncbi.nlm.nih.gov/pubmed/33912868 http://dx.doi.org/10.21037/aol-20-47 |
Ejemplares similares
-
Update on Novel Therapeutics for Primary CNS Lymphoma
por: Schaff, Lauren R., et al.
Publicado: (2021) -
Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease
por: Ambady, Prakash, et al.
Publicado: (2017) -
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice
por: Ambady, Prakash, et al.
Publicado: (2021) -
Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—a narrative review
por: Krebs, Simone, et al.
Publicado: (2021) -
Primary central nervous system lymphoma: advances in MRI and PET imaging
por: Ambady, Prakash, et al.
Publicado: (2021)